ClinicalTrials.gg
Active, not recruitingNCT06599970DI-MOBUpdated Apr 22, 2026

Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility

An observational study in Dengue, Arbovirus Infections and Epidemic Disease, sponsored by Institute of Tropical Medicine, Belgium. Active, not recruiting at 1 site in Cuba. Open to participants aged 19 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Institute of Tropical Medicine, Belgium · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Other
Enrollment
810
Ages
19 Years to 75 Years
Sex
All
01

Study summary

In contrast to the trend expected based on existing prediction models, dengue incidence was historically low during the pandemic mobility restrictions of 2020-2021 in most dengue endemic countries. This highlights that current transmission models do not correctly take human mobility into account. Within a pilot-study in Cienfuegos, South-Central Cuba, we will characterise the epidemiological spread and distribution of dengue outbreaks (2012-2025) in districts repeatedly involved in previous dengue outbreaks as initiating, case-concentrating or transmission sustaining areas. This will be linked with fine-grained mobility data and socio-spatial characterizations of commuting flows and population hubs where people are concentrated during day-time (time when transmission happens). This information, together with entomological and environmental risk-data, will be used to i) improve the accuracy of mathematical dengue models, ii) better understand the transmission process and iii) inform and improve the design of disease control strategies. The project will contribute to much-needed evidence-based guidance for public health actors on improved prevention strategies of epidemics dispersion and where and when to implement control measures.

Read the detailed description

Using epidemiological data and human mobility data, integrated with other multiple-sourced data, this study examines the interplay between disease spread and intra-city mobility (within a city).

The study is ambi-spective, using retro- and prospective routine surveillance data (2012-2025) on dengue cases and Aedes entomological data, to describe the fine-scale spatio-temporal characterization of dengue transmission in Cienfuegos municipality.

To characterise human mobility within the municipality of Cienfuegos, information related to recurrent and seasonal movements will be collected. Several types of data will be triangulated to obtain a comprehensive understanding of the population's mobility (matrix of human mobility). In this way, six prospective data collection activities are planned:

  1. Mobility survey: The conduct of a mobility survey with adults. The purpose of this survey is to gather prospective information regarding recurrent mobility, and retrospective information about seasonal mobility. Study subjects include adults, elderly, and indirectly, young children through the specific inclusion of young mothers.
  2. Student survey: Questionnaire about mobility of a sample of students in pre-university and university on recurrent and seasonal mobility.
  3. School registers: Consultation of school registers to capture information on school-related recurrent mobility of children of school-going age.
  4. Vacation stories: Within a two-weeks time after the holidays, teachers are always doing a 'vacation story exercise' within their class. We will ask the teachers of selected classes in the sentinel schools to group this information on the number of children travelling outside the Cienfuegos municipality during holidays (seasonal mobility).
  5. Workplace register: Consultation of workplace registers to capture information on work-related recurrent mobility of adults.
  6. Call Detail Records: Anonymized and grouped information about house-work/school locations of cell phone users obtained from cell phone company (recurrent movement).

In a third step, the above information will be brought into a mathematical model, explaining mobility within transmission dynamics, which will be validated in a prospective way allowing to identify shortcomings and adjust the model where needed.

In a last step, the various types of collected data will be assembled and discussed together for the elaboration of potential dengue (and integrated) control strategies and presented for validation with local stakeholders.

02

Conditions studied

  • Dengue
  • Arbovirus Infections
  • Epidemic Disease
  • Behavior, Health

Keywords

  • human mobility
  • transmission modelling
  • socio-spatial characterization
03

In context

Dengue

283 studies on the registry are indexed under Dengue; 44 are open to participants now.

This study's planned enrollment of 810 is above the median of 595 across 80 observational studies indexed under Dengue.

Browse Dengue studies →

Lead sponsor

Institute of Tropical Medicine, Belgium is the lead sponsor of 104 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Research will take place in Cienfuegos municipality, Cuba, with a population of 178 776 inhabitants. For the epidemiological and entomological data, routine surveillance info will be used, which covers the entire municipality.

For mobility patterns characterisation, for example the mobility survey: we selected (based on epidemiological patterns) 5 sentinel Popular Councils. Within each, 4 consultorios and their area of coverage were selected. In the consultorium exists a health registry, a list of all persons in the consultorium catchment area. Participants will be selected from the health registry by a random process using the RANDBETWEEN function in Microsoft Excel, within a range of 1 to upper limit equal to the total number of patients in the registry.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

For the prospective data collection - mobility survey:

Inclusion criteria

Inclusion Criteria:

  • Being a resident of the sentinel Popular Council/consultorio
  • Being >= 19 years of age
  • Being willing and able to provide written

Exclusion criteria

Exclusion Criteria:

  • being below 19 or above 75 years old
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Ecologic or community
Time perspective
Other
Enrollment
810 participants (estimated)
Patient registry
No

Interventions

  • OtherNo intervention

    This is an observational study. No experimental interventions included. The mobility of people will be studied.

06

What researchers measure

Primary outcomes

  1. dengue incidence

    multilevel spatio-temporal characterization of dengue transmission dynamics, focussing on transmission propagation heterogeneity in time and space

    Time frame: 2012-2025

  2. human mobility

    origen-destination matrices will be built, based on information collected in mobility survey, school and workplace registries, vacation stories, phone data, student survey and in-depth interviews

    Time frame: 2024-2026

Secondary outcomes

  1. entomological risks for dengue transmission

    entomological indicators (monthly data collection of immature stages 2012-2025; monthly surveys of adult stages Aedes mosquitoes 2024-2025)

    Time frame: 2012-2025

  2. climate

    temperature (° degrees celsius, daily minimum, daily maximum, weekly average) and rainfall (mm/day)

    Time frame: 2012-2026

  3. Mathematical transmission model

    Stochastic mobility-driven spatially explicit DENV model based on the two primary outcomes of this study

    Time frame: 2024-2026

  4. socio-spatial characterisation of public spaces

    hourly population densities (number of persons present for more than 5 minutes present) in different rooms/areas of densely frequented public spaces (schools, markets, factories)

    Time frame: 2024-2026

07

Study locations

1 site
  • Instituto de Medicina Tropical Pedro Kouri
    Havana, La Habana, Cuba
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06599970
Collaborators
Cienfuegos Provincial Ministry of Health, Cuba, University Ghent, Institute Pedro Kouri, Ministry of Public Health (Cuba)
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Jun 1, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Apr 22, 2026

Study contacts

Veerle Vanlerberghe
study director · Institute of Tropical Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion